Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients. Reumatismo [Internet]. 2014 Mar. 17 [cited 2025 Jun. 20];65(6):278-85. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2013.682